Comment: Barbiturates may enhance adverse outcomes, together with respiratory melancholy, produced by toxic doses of TCAs. With therapeutic doses of TCAs, barbiturates enhance metabolism and decrease blood concentrations of TCAs.Keep away from; coadministration with CYP3A inducers may possibly bring about diminished plasma concentrations of elviteg